Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 4:53 AM
Ignite Modification Date: 2025-12-26 @ 3:54 AM
NCT ID: NCT03963518
Description: Adverse events (serious and non-serious) were not collected for the purpose of this study
Frequency Threshold: 0
Time Frame: up to 4 years after the start of treatment Only all-cause mortality was collected for the purpose of this study. Adverse events (serious and non-serious) were not collected for the purpose of this study.
Study: NCT03963518
Study Brief: Immune-checkpoint Inhibitors and Surrogate Endpoints in Cancer Trials (SURROGATE-ICI)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Control nivolumab monotherapy nivolumab monotherapy: nivolumab monotherapy 175 None 0 0 0 0 View
Experimental nivolumab plus ipilimumab nivolumab plus ipilimumab: nivolumab plus ipilimumab 151 None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):